Elevated methemoglobin levels in patients treated with hydroxocobalamin: a case series and in-vitro analysis

References

• Dart RC, Goldfrank LR, Erstad BL, et al. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med. 2018;71(3):314–325 e1.
   PubMed Web of Science ®Google Scholar
• Cashin BV, Matlock AG, Kang C, et al. Effect of hydroxocobalamin on surface oximetry in nonexposed humans. Prehosp Disaster Med. 2013;28(4):367–369.
   PubMedGoogle Scholar
• Kirk MA, Gerace R, Kulig KW. Cyanide and methemoglobin kinetics in smoke inhalation victims treated with the cyanide antidote kit. Ann Emerg Med. 1993;22(9):1413–1418.
   PubMed Web of Science ®Google Scholar
• Jiwani AZ, Bebarta VS, Cancio LC. Acquired methemoglobinemia after hydroxocobalamin administration in a patient with burns and inhalation injury. Clinical Toxicology. 2018;56(5):370–2.
   Web of Science ®Google Scholar
• Kiernan E, Carpenter JE, Dunkley CA, et al. Elevated methemoglobin levels in a patient treated with hydroxocobalamin after suspected cyanide exposure. J Emerg Med. 2020;59(5):e157–e62.
   PubMedGoogle Scholar
• Beckerman N, Leikin SM, Aitchinson R, et al. Laboratory interferences with the newer cyanide antidote: hydroxocobalamin. Semin Diagn Pathol. 2009;26(1):49–52.
   PubMedGoogle Scholar
• Ranjitkar P, Greene DN. Therapeutic concentrations of hydroxocobalamin interferes with several spectrophotometric assays on the beckman coulter DxC and AU680 chemistry analyzers. Clin Chim Acta. 2015;450:110–114.
   PubMedGoogle Scholar
• Pace RW, Lugassy D, Hoffman RS. Letter in response to “Acquired methemoglobinemia after hydroxocobalamin administration in a patient with burns and inhalation injury”. Clinical Toxicology (Philadelphia, Pa.). 2017;56(6):451–2.
   PubMedGoogle Scholar
• Lee J, Mukai D, Kreuter K, et al. Potential interference by hydroxocobalamin on cooximetry hemoglobin measurements during cyanide and smoke inhalation treatments. Ann Emerg Med. 2007;49(6):802–805.
   PubMedGoogle Scholar
• Pamidi PVA, DeAbreu M, Kim D, et al. Hydroxocobalamin and cyanocobalamin interference on co-oximetry based hemoglobin measurements. Clin Chim Acta. 2009;401(1-2):63–67.
   PubMed Web of Science ®Google Scholar
• Denninghoff K, Walter FG, Langa AJ, et al. Spectrophotometry of hydroxocobalamin and hemoglobin reveals production of an unanticipated methemoglobin variant. Clin Toxicol (Phila). 2008;46(6):545–550.
   PubMed Web of Science ®Google Scholar
• Cortazzo JA, Lichtman AD. Methemoglobinemia: a review and recommendations for management. J Cardiothorac Vasc Anesth. 2014;28(4):1043–1047.
   PubMed Web of Science ®Google Scholar
• Zijlstra WG, Buursma A, Meeuwsen-van der Roest WP. Absorption spectra of human fetal and adult oxyhemoglobin, de-oxyhemoglobin, carboxyhemoglobin, and methemoglobin. Clin Chem. 1991;37(9):1633–1638.
   PubMed Web of Science ®Google Scholar
• Forsyth JC, Mueller PD, Becker CE, et al. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol. 1993;31(2):277–294.
   PubMed Web of Science ®Google Scholar
• Hurford WE, Kratz A. Case records of the Massachusetts general hospital. Weekly clinicopathological exercises. Case 23-2004. A 50-year-old woman with low oxygen saturation. N Engl J Med. 2004;351(4):380–387
   PubMed Web of Science ®Google Scholar
• Baud FJ, Borron SW, Megarbane B, et al. Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit Care Med. 2002;30(9):2044–2050.
   PubMed Web of Science ®Google Scholar
• Baud FJ, Barriot P, Toffis V, et al. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med. 1991;325(25):1761–1766.
   PubMed Web of Science ®Google Scholar
• Ballantyne B, Marrs T. Post-mortem features and criteria for the diagnosis of acute lethal cyanide poisoning. In: Ballantyne B, Marrs T, editors. Clinical and experimental toxicology of cyanides; 1987. p. 217–247. Oxford, UK: John Wiley & Sons.
   Google Scholar
• Grabowska T, Skowronek R, Nowicka J, et al. Prevalence of hydrogen cyanide and carboxyhaemoglobin in victims of smoke inhalation during enclosed-space fires: a combined toxicological risk. Clin Toxicol. 2012;50(8):759–763.
   Web of Science ®Google Scholar
• Johnson RP, Mellors JW. Arteriolization of venous blood gases: a clue to the diagnosis of cyanide poisoning. J Emerg Med. 1988;6(5):401–404.
   PubMedGoogle Scholar
• Martín-Bermúdez R, Maestre-Romero A, Goñi-Belzunegui MV, et al. Venous blood arteriolization and multiple organ failure after cyanide poisoning. Intensive Care Med. 1997;23(12):1286.
   PubMedGoogle Scholar
• Product information: CYANOKIT(R) 2.5g IV injection, hydroxocobalamin IV injection. Lyon, France: Merck Lipha Sante; 2006.
   Google Scholar
• McEnroe RD, Durham AP. CLSI interference testing in clinical chemistry; approved guideline. Clsi ep07. 3rd ed. Wayne, PA: Clinical Laboratory Standards Institute; 2017.
   Google Scholar
• DesLauriers CA, Burda AM, Wahl M. Hydroxocobalamin as a cyanide antidote. Am J Ther. 2006;13(2):161–165.
   PubMedGoogle Scholar
• Hoffman RS, Sauter D. Methemoglobinemia resulting from smoke inhalation. Vet Hum Toxicol. 1989;31(2):168–170.
   PubMedGoogle Scholar
• Alarie Y. Toxicity of fire smoke. Crit Rev Toxicol. 2002;32(4):259–289.
   PubMed Web of Science ®Google Scholar
• Tarburton JP, Metcalf WK. Kinetics of amyl nitrite-induced hemoglobin oxidation in cord and adult blood. Toxicology. 1985;36(1):15–21.
   PubMedGoogle Scholar
• Skold A, Cosco DL, Klein R. Methemoglobinemia: pathogenesis, diagnosis, and management. South Med J. 2011;104(11):757–761.
   PubMed Web of Science ®Google Scholar
• Pushparajah Mak RS, Liebelt EL. Methylene blue: an antidote for methemoglobinemia and beyond. Pediatr Emerg Care. 2021;37(9):474–477.
   PubMedGoogle Scholar
• Rosen PJ, Johnson C, McGehee WG, et al. Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med. 1971;75(1):83–86.
   PubMed Web of Science ®Google Scholar
• Patnaik S, Natarajan MM, James EJ, et al. Methylene blue unresponsive methemoglobinemia. Indian J Crit Care Med. 2014;18(4):253–255.
   PubMedGoogle Scholar
• Yamaji F, Soeda A, Shibata H, et al. A new mutation of congenital methemoglobinemia exacerbated after methylene blue treatment. Acute Med Surg. 2018;5(2):199–201.
   PubMedGoogle Scholar